Clinical Trial Update: 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating 131I-L19SIP radioimmunotherapy combined with radiochemotherapy in locally advanced non-small cell lung cancer; the study status is TERM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 131I-L19SIP (L19SIP radiopharmaceutical (radioimmunotherapy))

Snippet

Sponsor: Philogen S.p.A. | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: TERMINATED